微波消融
免疫疗法
乳腺癌
阶段(地层学)
肿瘤科
医学
烧蚀
免疫系统
内科学
CD8型
癌症
外科
免疫学
生物
古生物学
作者
Yao Xiao,Song‐Yang Wu,Yi‐Zhou Jiang
出处
期刊:Med
[Elsevier]
日期:2024-04-01
卷期号:5 (4): 278-280
被引量:1
标识
DOI:10.1016/j.medj.2024.02.004
摘要
Immunotherapy has enhanced breast cancer outcomes, but optimizing combination therapies is crucial. Integrating additional treatment modalities, like physical therapies, holds promise for optimizing efficacy. Pan et al. recently reported that combining preoperative immunotherapy with microwave ablation is safe and feasible in early-stage breast cancer, effectively sensitizing peripheral CD8+ T cells. 1 Pan H. Yu M. Tang X. Mao X. Liu M. Zhang K. Qian C. Wang J. Xie H. Qiu W. et al. Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A randomized window-of-opportunity trial. Med. 2024; https://doi.org/10.1016/j.medj.2024.01.015 Abstract Full Text Full Text PDF Scopus (1) Google Scholar Immunotherapy has enhanced breast cancer outcomes, but optimizing combination therapies is crucial. Integrating additional treatment modalities, like physical therapies, holds promise for optimizing efficacy. Pan et al. recently reported that combining preoperative immunotherapy with microwave ablation is safe and feasible in early-stage breast cancer, effectively sensitizing peripheral CD8+ T cells. 1 Pan H. Yu M. Tang X. Mao X. Liu M. Zhang K. Qian C. Wang J. Xie H. Qiu W. et al. Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A randomized window-of-opportunity trial. Med. 2024; https://doi.org/10.1016/j.medj.2024.01.015 Abstract Full Text Full Text PDF Scopus (1) Google Scholar Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trialPan et al.MedFebruary 27, 2024In BriefInnovative treatments are still needed to reduce metastatic disease for early-stage breast cancer. Pan et al. found that local microwave ablation combined with camrelizumab showed a favorable local effect and systemic immune response in the treatment of early-stage breast cancer, and the long-term effect of this strategy is worth investigating. Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI